Dr. John R. Shaffer's lab focuses on understanding the genetic basis of oral diseases like dental caries and periodontitis, which affect billions of people worldwide. By conducting extensive genetic research and collaboration with over 800,000 participants, the lab aims to uncover new genetic associations and enhance tools for predicting and preventing these diseases. The ultimate goal is to improve oral health outcomes and reduce disparities in dental care through personalized approaches based on genetic insights.

Dr. Milos Hauskrecht's lab at the University of Pittsburgh focuses on improving clinical care through advanced alerting systems that leverage electronic medical records (EMR) and machine learning. The lab is developing innovative ways to predict and alert healthcare providers to potential medical errors, especially in intensive care units (ICUs). By combining data-driven insights with human expertise, they aim to enhance patient safety and optimize clinical decision-making.

Dr. Anne Marie Robertson's lab focuses on improving medical treatments for bladder problems, like those caused by benign prostate enlargement, and enhancing risk assessment for brain aneurysms. The lab aims to create digital models that simulate bladder and aneurysm behavior to better understand their mechanics and develop tailored treatment strategies. This research is vital for designing more effective surgical and pharmacological interventions, ultimately improving patient outcomes.

Dr. Lu Tang's lab at the University of Pittsburgh focuses on enhancing the safety and effectiveness of machine learning algorithms in medical decision-making, specifically for sepsis treatment. By analyzing a large dataset from sepsis patients, the lab aims to create algorithms that can provide personalized treatment recommendations while managing risks and uncertainties. The research aims not only to develop novel methods but also to translate these improvements into user-friendly software for practical use in healthcare settings.

Dr. George C. Tseng's lab focuses on improving cancer research by developing methods to evaluate and select the best laboratory models that mimic real human tumors. Using advanced techniques like single-cell RNA sequencing, the lab aims to understand the diversity within tumors and how this affects treatment responses. Their work is crucial for advancing precision medicine and optimizing cancer therapies.